T1	Intervention 30 35	YM17E
T2	Intervention 168 210	single and repeat oral dose study of YM17E
T3	Intervention 591 634	3, 60 and 300 mg or 15, 60 and 450 mg YM17E
T4	Intervention 447 482	YM17E was administered after a meal
T5	Intervention 539 554	taking the drug
T6	Intervention 565 579	taking placebo
T7	Intervention 843 849	450 mg
T8	Intervention 880 886	300 mg
T9	Intervention 1384 1440	150 mg YM17E in both the fasted and post-prandial states
T10	Intervention 1881 1922	repeated oral administration of 150 mg b.
T11	Intervention 1972 1977	day 5
T12	Intervention 2010 2047	repeated administration of 300 mg b.d
T13	Intervention 2125 2132	5th day
T14	Intervention 2197 2204	7th day
T15	Intervention 2301 2352	single and repeated oral dose studies at 150 mg b.d
T16	Intervention 2498 2516	300 mg twice daily
